News Information and Media Site: 'It's turned into a free-for-all': Inside the bungled U.S. rollout of Pfizer's antiviral pills

Saturday, February 5, 2022

'It's turned into a free-for-all': Inside the bungled U.S. rollout of Pfizer's antiviral pills

Feb 05, 2022

'It's turned into a free-for-all': Inside the bungled U.S. rollout of Pfizer's antiviral pills

Pfizer's five-day oral Covid-19 treatment, which holds considerable potential as a weapon against the pandemic, has remained in woefully short supply since its Dec. 22 emergency authorization. Even in the face of the treatment's scarcity, many state health departments have not sought to restrict Paxlovid's availability to those at the very highest risk of hospitalization and mortality.